Purchase Order 75N90023P00721

Award Date 8/17/23
Potential Completion Date 9/30/23
Potential Value $27K
Federal Agency
NIH Clinical Center
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20814, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services National Institutes of Health (NIH) Clinical Center awarded a $24,895.00 firm fixed-price purchase order to Q Squared Solutions Expression Analysis LLC, doing business as Expression Analysis, for clinical trial laboratory services. The contract, which does not have a set-aside designation, will provide comprehensive testing, project management, supply chain, biospecimen, and consent management solutions to support medical research efforts at NIH...
This firm fixed-price purchase order was awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Q Squared Solutions Expression Analysis LLC, doing business as Expression Analysis. The $15,290.00 contract provides RNA sequencing services, including RNA isolation, TruSeq Stranded mRNA sequencing, and RNA sequence counts, to support the research activities of the Division of Intramural Research within...
The Department of Health and Human Services' National Institutes of Health's National Institute of Child Health and Human Development awarded a $9,430.81 purchase order to Q Squared Solutions Expression Analysis LLC for ILLUMINA GAII DNA sequencing services for 72 bases per lane. The prime contractor, doing business as Expression Analysis, will perform the sequencing services at its location in Durham, North Carolina over an eight-day period concluding on December 30, 2010. The contract is a...
This federal contract award, with an ID of HHSN273201600008I|HHSN27300001, was issued by the National Institute of Environmental Health Sciences (NIEHS), a civilian agency under the Department of Health and Human Services (HHS). The $32,890.00 firm fixed-price delivery order contract was awarded to Q Squared Solutions Expression Analysis LLC, doing business as Expression Analysis, a for-profit limited liability company. The contract is for the provision of genomic sequencing, testing, and...
This federal contract award, valued at $17,389.50, was issued by the National Institute of Environmental Health Sciences (NIEHS), a civilian agency within the U.S. Department of Health and Human Services. The contract was awarded to Q Squared Solutions Expression Analysis LLC, doing business as Expression Analysis, a for-profit limited liability company that specializes in genomic sequencing, testing, and analysis services for medical research. The award is for "EXPRESSION...
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $22,646 purchase order to Illumina, Inc. for service agreement on a NovaSeq 6000 sequencer. The firm fixed price contract runs from December 1, 2023 through January 17, 2024 and will be performed in Rockville, Maryland. This purchase order provides sequencing services utilizing Illumina's NovaSeq 6000 platform to support the National Cancer Institute's cancer research efforts. No major...
The National Institute of Environmental Health Sciences (NIEHS), a civilian agency within the U.S. Department of Health and Human Services, awarded a $35,750 firm-fixed-price delivery order contract to Q Squared Solutions Expression Analysis LLC, doing business as Expression Analysis. The contract is for the provision of genomic sequencing, testing, and analysis services to support medical research efforts, particularly in the areas of cancer research and personalized medicine. Expression...
This federal contract award to Q Squared Solutions Expression Analysis LLC, doing business as Expression Analysis, was issued by the National Institute of Environmental Health Sciences (NIEHS), a civilian agency within the U.S. Department of Health and Human Services. The $24,200 Firm Fixed Price Delivery Order contract, awarded on September 18, 2015, is for the provision of genomic sequencing, testing, and analysis services to support medical research, particularly in the areas of cancer...
This $467,900 firm fixed price purchase order was awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS), to Qiagen, LLC. The contract calls for Qiagen to provide clinical interpretation services for genomic variants identified through large next-generation gene panels, whole exome sequencing, and whole transcriptome sequencing conducted as part of NCI's Clinical Oncologic Molecular Pathology...
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded Purchase Order 20019983 to Illumina, Inc. for $15,575. The order is for an MISEQ Silver Support Plan (SV-420-1003) to be performed at the prime contractor's facility in Bethesda, Maryland from August 1, 2023 through July 31, 2024. The firm fixed price contract provides support services for the MISEQ sequencing system serial number M01303 in support of the NIH National Cancer Institute's...

The Department of Health and Human Services National Institutes of Health Clinical Center awarded a $26,926 purchase order to Q Squared Solutions Expression Analysis LLC for oncogene sequencing assay services. Under this firm fixed price contract, Expression Analysis will provide sequencing of cancer-related genes to support research at the NIH Clinical Center in Bethesda, Maryland through September 30, 2023. No major subcontractors or set aside designations were identified. This purchase order is likely a component of the NIH Clinical Center's broader efforts to advance personalized cancer treatment through genomic analysis.

Generated 12/21/23, 11:58 PM